Support Line: 0800 002 9002
General Enquiries: 01223 870008

News Archive

Kidney Cancer News

Resilience Over Adversity: The Mental Toll of VHL

Resilience Over Adversity: The Mental Toll of VHL

Living with a rare disease can be challenging enough, especially when it impacts you physically. But for those ...
Highest risk patients with RCC benefit from adjuvant everolimus

Highest risk patients with RCC benefit from adjuvant everolimus

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell ...
Dovitinib Companion Diagnostic Shows Results in RCC

Dovitinib Companion Diagnostic Shows Results in RCC

The drug response predictor companion diagnostic for dovinitib (DRP-Dovitinib) demonstrates potential to identify ...
Clinical Trial News – PEAR-TREE 2

Clinical Trial News – PEAR-TREE 2

Exploring how to match treatments to patients Patients with advanced or metastatic kidney cancer now have a range ...
NICE recruiting committee members for kidney cancer guideline

NICE recruiting committee members for kidney cancer guideline

The National Institute for Health and Care Excellence (NICE) is recruiting members for the committee that will ...
Genetic variants help uncover potential new treatment pathway in kidney cancer

Genetic variants help uncover potential new treatment pathway in kidney cancer

Investigators have found that inhibition of the purine salvage pathway in hereditary leiomyomatosis and renal cell ...
New Nephrectomy Support Fact Sheets

New Nephrectomy Support Fact Sheets

Kidney Cancer UK is delighted to announce that collaboration with senior NHS clinicians has resulted in the ...
Patient’s tumour removed in world-first histotripsy treatment at Leeds Cancer Centre

Patient’s tumour removed in world-first histotripsy treatment at Leeds Cancer Centre

A cancer patient from West Yorkshire has become the first person in the world to have a kidney tumour removed ...
Belzutifan+cabozantinib shows promise for advanced RCC, study shows

Belzutifan+cabozantinib shows promise for advanced RCC, study shows

belzutifan+cabozantinib combination therapy show promise as an option for advanced kidney cancer patients already ...
TKI Treatment Breaks May Not Impact Outcomes in RCC

TKI Treatment Breaks May Not Impact Outcomes in RCC

Patients with advanced clear cell renal cell carcinoma are “unlikely” to experience a clinically meaningful ...
East Midlands Kidney Cancer Support Group

East Midlands Kidney Cancer Support Group

Join the East Midlands Kidney Cancer Support Group   📆 Our next meeting is Friday 6th February, 11am - 2pm ...
No results found.